Based on recent data, Vir Biotechnology, Inc. (VIR) shows an Average True Range (ATR) of 0.73 and an Enterprise Value of 961.88M. Its average trading volume over the past 3 months is 1.87M, indicating liquidity. These fundamental metrics provide insight into VIR's underlying financial health and market activity.
| ATR | 0.73 |
| Enterprise Value | 961.88M |
| Avg Vol (3 Months) | 1.87M |
| Avg Vol (10 Days) | 1.71M |
Vir Biotechnology, Inc. (VIR) technical indicators as of July 28, 2026: the SMA 20 is 19.06%, SMA 50 at 34.25%, and SMA 200 at 61.64%. The RSI 14 value is 66.17, suggesting its current momentum. These technical analysis signals help assess VIR's price trends and potential future movements.
| SMA 20 | 19.06% |
| SMA 50 | 34.25% |
| SMA 200 | 61.64% |
| RSI 14 | 66.17 |
Vir Biotechnology, Inc. (VIR) stock performance overview as of July 28, 2026: The 52-week high is $11.66 (currently -14.81% below), and the 52-week low is $4.16 (currently 124.31% above). Over the past year, VIR's performance is -40.3%, compared to the S&P 500's 3.36% change.
| 52-Week High | 11.66 |
| 52-Week High Chg | -14.81% |
| 52-Week Low | 4.16 |
| 52-Week Low Chg | +124.31% |
| S&P 500 52-Week Chg | 3.36% |
According to market data, Vir Biotechnology, Inc. (VIR) stock's recent performance metrics show that over the last month, VIR is -2.28%, with a Year-to-Date (YTD) performance of -0.5%. Over the past year, the stock has seen a -40.3% change. These figures summarize VIR's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 9.59 | 10.58 | 10.96 | 11.66 | 11.66 | 11.66 |
| Low | 8.62 | 8.62 | 8.16 | 5.8 | 4.16 | 5.55 |
| Performance | +1.35% | -2.28% | +3.81% | +8.70% | -40.30% | -0.50% |
According to current financial data, VIR stock's P/E (TTM) ratio is -2.80, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for VIR, including P/S (22.59), P/B (1.59), and P/FCF (-3.33), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | VIR | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -2.8 | -1.24 | -194.78 | 32.59 |
| P/S (TTM) | 22.59 | 3.7 | 468.69 | 5.98 |
| P/B (TTM) | 1.59 | 0.25 | -3496.43 | 5.59 |
| P/FCF (TTM) | -3.33 | -5.21 | -619.54 | 31.65 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep